AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions
Go back to AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions| (NASDAQ: ABCL) | Delayed: 9.34 +2.41 (34.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.93 | 52 Week High | $ | |||
| Open | $8.76 | 52 Week Low | $ | |||
| Day High | $10.01 | P/E | N/A | |||
| Day Low | $8.40 | EPS | $ | |||
| Volume | 46,022,181 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 523.91 +27.84 (5.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $496.07 | 52 Week High | $134.71 | |||
| Open | $539.50 | 52 Week Low | $73.31 | |||
| Day High | $546.17 | P/E | N/A | |||
| Day Low | $519.82 | EPS | $-1.98 | |||
| Volume | 2,682,390 | |||||
